Open-Label Safety Study of AXS-05 in Subjects With Depression

Clinical trial NCT04039022 · COMPLETED

Trial details

NCT number: NCT04039022
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Treatment Resistant Depression Depression

Start date: 2019-07-08
Primary completion: 2020-10-23
Enrollment: 876

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.